Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial - PubMed

ClinicalTrials.gov, NCT03720470.
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov